{"id":"https://openalex.org/W4380082910","doi":"https://doi.org/10.1158/1538-7445.am2023-1533","title":"Abstract 1533: ZW220, a novel NaPi2b-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","display_name":"Abstract 1533: ZW220, a novel NaPi2b-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4380082910","doi":"https://doi.org/10.1158/1538-7445.am2023-1533"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-1533","doi":"https://doi.org/10.1158/1538-7445.am2023-1533","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-1533","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056200860","display_name":"Andrea Hern\u00e1ndez Rojas","orcid":"https://orcid.org/0000-0002-0278-9434","observed_orcids":["https://orcid.org/0000-0002-0278-9434"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Andrea Hernandez Rojas","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031726220","display_name":"Jodi Wong","orcid":"https://orcid.org/0009-0004-8505-2690","observed_orcids":["https://orcid.org/0009-0004-8505-2690"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jodi Wong","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072941072","display_name":"Dunja Urosev","orcid":"https://orcid.org/0009-0002-6679-028X","observed_orcids":["https://orcid.org/0009-0002-6679-028X"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Dunja Urosev","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011615044","display_name":"Samuel O. Lawn","orcid":"https://orcid.org/0009-0005-8033-6990","observed_orcids":["https://orcid.org/0009-0005-8033-6990"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sam Lawn","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033698777","display_name":"Kaylee J. Wu","orcid":"https://orcid.org/0009-0009-6827-5960","observed_orcids":["https://orcid.org/0009-0009-6827-5960"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kaylee Wu","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029930966","display_name":"Saki Konomura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Saki Konomura","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032258154","display_name":"Manuel Lasalle","orcid":"https://orcid.org/0000-0001-5597-3289","observed_orcids":["https://orcid.org/0000-0001-5597-3289"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Manuel Lasalle","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042018789","display_name":"D.A. Alonzo","orcid":"https://orcid.org/0000-0002-3586-3485","observed_orcids":["https://orcid.org/0000-0002-3586-3485"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Diego A. Alonzo","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112423187","display_name":"Luying Yang","orcid":"https://orcid.org/0009-0005-6232-0151","observed_orcids":["https://orcid.org/0009-0005-6232-0151","https://orcid.org/0009-0003-7711-5252"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Luying Yang","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103028352","display_name":"Mark E. Petersen","orcid":"https://orcid.org/0000-0003-2629-1363","observed_orcids":["https://orcid.org/0000-0003-2629-1363"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark Petersen","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089356754","display_name":"Lemlem T. Degefie","orcid":"https://orcid.org/0000-0001-6927-8973","observed_orcids":["https://orcid.org/0000-0001-6927-8973"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lemlem T. Degefie","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087508687","display_name":"Araba P. Sagoe-Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Araba P. Sagoe-Wagner","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033883885","display_name":"Sohyeong Kang","orcid":"https://orcid.org/0000-0002-1352-2508","observed_orcids":["https://orcid.org/0000-0002-1352-2508"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sohyeong Kang","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051168917","display_name":"Chi Wing Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chi Wing Cheng","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020780697","display_name":"Raffaele Colombo","orcid":"https://orcid.org/0000-0001-5709-4704","observed_orcids":["https://orcid.org/0000-0001-5709-4704"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Raffaele Colombo","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030785436","display_name":"Dayananda Siddappa","orcid":"https://orcid.org/0000-0003-2682-5409","observed_orcids":["https://orcid.org/0000-0003-2682-5409"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Daya Siddappa","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069995028","display_name":"Stuart D. Barnscher","orcid":"https://orcid.org/0009-0000-2386-5240","observed_orcids":["https://orcid.org/0009-0000-2386-5240"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Stuart D. Barnscher","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069149184","display_name":"Jamie R. Rich","orcid":"https://orcid.org/0009-0008-0926-1318","observed_orcids":["https://orcid.org/0009-0008-0926-1318"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jamie R. Rich","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210098574"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"1533","last_page":"1533"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.2222999930381775,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.902999997138977},{"id":"https://openalex.org/keywords/napi2b","display_name":"NaPi2b","score":0.9829999804496765},{"id":"https://openalex.org/keywords/slc34a2","display_name":"SLC34A2","score":0.9959999918937683},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8870000243186951},{"id":"https://openalex.org/keywords/camptothecin-derivatives","display_name":"camptothecin derivatives","score":0.8080000281333923},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.765999972820282},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9070000052452087},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.5220000147819519},{"id":"https://openalex.org/keywords/bystander-effect","display_name":"bystander effect","score":0.8759999871253967},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6011413335800171},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.5517477989196777},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.48954448103904724},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4805486798286438},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.47450515627861023},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4493350684642792},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.44250568747520447},{"id":"https://openalex.org/C2777092746","wikidata":"https://www.wikidata.org/wiki/Q5939625","display_name":"Humanized antibody","level":4,"score":0.4307325780391693},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4233506917953491},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4043505787849426},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3723525106906891},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.33194297552108765},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3198867440223694},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.31911104917526245},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2886239290237427},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1933521330356598},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16606146097183228},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-1533","doi":"https://doi.org/10.1158/1538-7445.am2023-1533","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-1533","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393073399","https://openalex.org/W4403749020","https://openalex.org/W4393085544","https://openalex.org/W4379983442","https://openalex.org/W2136344029","https://openalex.org/W2487451536","https://openalex.org/W4409626642","https://openalex.org/W4412475105","https://openalex.org/W4393090292","https://openalex.org/W2603196594"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"NaPi2b":[2,16,35,169],"is":[3,17,26,36,48,61,75],"a":[4,57,78,82,149,166,182,240,246,262,285,347,354],"multi-pass":[5],"transmembrane":[6],"sodium-dependent":[7],"phosphate":[8,21],"transport":[9],"protein":[10],"encoded":[11],"by":[12],"the":[13,29,107,112,141,280,363],"gene":[14],"SLC34A2.":[15],"involved":[18],"in":[19,28,39,73,97,100,128,148,179,208,212,219,232,255,266,296],"normal":[20],"homeostasis":[22],"and":[23,32,44,81,92,99,111,121,134,158,198,205,222,227,375],"its":[24,273],"expression":[25],"found":[27],"lung,":[30],"liver,":[31],"small":[33],"intestine.":[34],"highly":[37],"expressed":[38],"ovarian":[40,133,159,243],"carcinomas,":[41],"lung":[42,135],"adenocarcinomas,":[43],"colorectal":[45],"carcinomas.":[46],"ZW220":[47,74,125,145,176,192,214,253,260,283],"an":[49],"antibody-drug":[50],"conjugate":[51,352],"(ADC)":[52],"targeting":[53],"human":[54,186,197],"NaPi2b,":[55,201],"wherein":[56],"humanized":[58],"IgG1":[59],"antibody":[60,193,350],"conjugated":[62],"to":[63,105,196,272],"novel":[64,286,348],"camptothecin-based":[65],"topoisomerase":[66,355],"I":[67],"inhibitor,":[68],"ZD06519.":[69],"The":[70,117,171,237],"drug":[71,351],"linker":[72],"comprised":[76],"of":[77,96,109,115,124,144,151,168,175,239,242,249,252,282,362],"maleimide":[79],"anchor":[80],"glycyl":[83,84],"phenylalanyl":[85],"glycine":[86],"(GGFG)-aminomethyl":[87],"(AM)":[88],"cleavable":[89],"sequence.":[90],"Materials":[91],"Methods:":[93],"A":[94],"series":[95],"vitro":[98,129],"vivo":[101],"studies":[102],"were":[103,126],"conducted":[104],"interrogate":[106],"mechanism":[108],"action":[110],"therapeutic":[113,287],"potential":[114,281],"ZW220.":[116],"binding,":[118],"internalization,":[119],"potency,":[120],"bystander":[122],"effect":[123],"evaluated":[127,147],"using":[130],"endogenous":[131],"NaPi2b-expressing":[132,209,299],"cancer":[136,233],"cell":[137,152,210,230,234],"lines.":[138],"In":[139],"vivo,":[140],"anti-tumor":[142],"activity":[143],"was":[146,177],"panel":[150,241],"line":[153],"derived":[154,161],"xenograft":[155,162],"(CDX)":[156],"models":[157,164,226],"patient":[160],"(PDX)":[163],"featuring":[165],"range":[167],"expression.":[170],"pharmacokinetic":[172],"(PK)":[173],"profile":[174,265],"determined":[178],"Tg32":[180,267],"mice,":[181,268],"transgenic":[183],"mouse":[184],"expressing":[185],"neonatal":[187],"Fc":[188],"receptor":[189],"(hFcRn).":[190],"Results:":[191],"exhibited":[194],"cross-reactivity":[195],"cynomolgus":[199],"monkey":[200],"nanomolar":[202],"binding":[203],"affinity":[204],"rapid":[206],"internalization":[207],"lines":[211],"vitro.":[213],"elicited":[215],"target-specific,":[216],"sub-nanomolar":[217],"cytotoxicity":[218],"two-dimensional":[220],"monolayer":[221],"three-dimensional":[223],"tumor":[224,257],"spheroid":[225],"demonstrated":[228,261],"bystander-mediated":[229],"killing":[231],"co-culture":[235],"assays.":[236],"treatment":[238],"PDXs":[244],"with":[245,269,298],"single":[247],"dose":[248],"6":[250],"mg/kg":[251],"resulted":[254],"robust":[256],"growth":[258],"inhibition.":[259],"favourable":[263],"PK":[264],"comparable":[270],"half-life":[271],"parental":[274],"unconjugated":[275],"antibody.":[276],"These":[277],"results":[278],"support":[279],"as":[284],"agent":[288],"which":[289],"may":[290],"help":[291],"address":[292],"unmet":[293],"medical":[294],"need":[295],"patients":[297],"tumors.":[300],"Citation":[301],"Format:":[302],"Andrea":[303],"Hernandez":[304],"Rojas,":[305],"Jodi":[306],"Wong,":[307],"Dunja":[308],"Urosev,":[309],"Sam":[310],"Lawn,":[311],"Kaylee":[312],"Wu,":[313],"Saki":[314],"Konomura,":[315],"Manuel":[316],"Lasalle,":[317],"Diego":[318],"A.":[319],"Alonzo,":[320],"Luying":[321],"Yang,":[322],"Mark":[323],"Petersen,":[324],"Lemlem":[325],"T.":[326],"Degefie,":[327],"Araba":[328],"P.":[329],"Sagoe-Wagner,":[330],"Sohyeong":[331],"Kang,":[332],"Chi":[333],"Wing":[334],"Cheng,":[335],"Raffaele":[336],"Colombo,":[337],"Daya":[338],"Siddappa,":[339],"Stuart":[340],"D.":[341],"Barnscher,":[342],"Jamie":[343],"R.":[344],"Rich.":[345],"ZW220,":[346],"NaPi2b-targeting":[349],"bearing":[353],"1":[356,373],"inhibitor":[357],"payload":[358],"[abstract].":[359],"In:":[360],"Proceedings":[361],"American":[364],"Association":[365],"for":[366],"Cancer":[367,386],"Research":[368],"Annual":[369],"Meeting":[370],"2023;":[371],"Part":[372],"(Regular":[374],"Invited":[376],"Abstracts);":[377],"2023":[378],"Apr":[379],"14-19;":[380],"Orlando,":[381],"FL.":[382],"Philadelphia":[383],"(PA):":[384],"AACR;":[385],"Res":[387],"2023;83(7_Suppl):Abstract":[388],"nr":[389],"1533.":[390]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-10T00:00:00"}